Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
EVO is expected to report earnings to fall 65.15% to -4 cents per share on November 05
Q3'25
Est.
$-0.05
Q2'25
Missed
by $0.07
Q1'25
Missed
by $0.09
Q4'24
Missed
by $0.09
Q3'24
Est.
$-0.12
The last earnings report on August 13 showed earnings per share of -14 cents, missing the estimate of -6 cents. With 43.22K shares outstanding, the current market capitalization sits at 1.33B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. EVO showed earnings on August 13, 2025. You can read more about the earnings report here.